Cooperation is a key business element for c-LEcta in developing innovative and efficient biotech solutions to the industry, and the company is always open for new partnerships.
Efficient joining of c-LEcta assets, namely its technology platforms, production capacities, and market implementation skills, with its partner’s strength in, for instance, product development, marketing, sales, and distribution, improves both partners’ business outcome.
c‑LEcta is flexible in defining fair and practical cooperation terms beneficial for both parties and in due respect of the project scope and the individual competence provided by each partner. Exclusivity, proprietary asset contribution, intellectual property ownership, market-risk dealing, and follow-up business opportunities, like product supply, are further factors that shape the overall cooperation setting.
Cooperation Strategy
Despite the uniqueness of each cooperation, c‑LEcta distinguishes long-term strategic alliances and project-focused partnerships as two major cooperation strategy routes. While Project Partnership often are linked to early development undertakings, Strategic Alliances additionally address market-near development and approval stages. Each route offers our partners the greatest flexibility toward their specific cooperation and development needs, their partnership flexibility, and their market control.
